Clinical Data Completes Sale of Genetic, PGx Test Business to Transgenomic

Transgenomic, which also raised $6 million in private funding to help pay for the acquisition, gains Clinical Data's Familion line of genetic tests for inherited heart diseases and biomarkers underlying the PGxPredict tests that predict drug response.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.